DE69431201D1 - Verwendung von indolderivaten als 5ht1-agonisten - Google Patents
Verwendung von indolderivaten als 5ht1-agonistenInfo
- Publication number
- DE69431201D1 DE69431201D1 DE69431201T DE69431201T DE69431201D1 DE 69431201 D1 DE69431201 D1 DE 69431201D1 DE 69431201 T DE69431201 T DE 69431201T DE 69431201 T DE69431201 T DE 69431201T DE 69431201 D1 DE69431201 D1 DE 69431201D1
- Authority
- DE
- Germany
- Prior art keywords
- agonists
- indolder derivatives
- indolder
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5393093A | 1993-04-27 | 1993-04-27 | |
| PCT/IB1994/000079 WO1994025023A1 (en) | 1993-04-27 | 1994-04-26 | Use of indole derivatives as 5ht1 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69431201D1 true DE69431201D1 (de) | 2002-09-26 |
| DE69431201T2 DE69431201T2 (de) | 2002-12-05 |
Family
ID=21987528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69431201T Expired - Fee Related DE69431201T2 (de) | 1993-04-27 | 1994-04-26 | Verwendung von indolderivaten als 5ht1-agonisten |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0696194B1 (de) |
| JP (1) | JP2922307B2 (de) |
| KR (1) | KR960701636A (de) |
| CN (3) | CN1121689A (de) |
| AP (1) | AP486A (de) |
| AT (1) | ATE222492T1 (de) |
| AU (1) | AU689469B2 (de) |
| BG (1) | BG61898B1 (de) |
| BR (1) | BR9406435A (de) |
| CA (1) | CA2161533C (de) |
| CO (1) | CO4230093A1 (de) |
| CZ (1) | CZ290416B6 (de) |
| DE (1) | DE69431201T2 (de) |
| DK (1) | DK0696194T3 (de) |
| ES (1) | ES2180573T3 (de) |
| HU (1) | HU222488B1 (de) |
| IL (1) | IL109376A (de) |
| MX (1) | MX9403088A (de) |
| NO (1) | NO308236B1 (de) |
| NZ (1) | NZ263614A (de) |
| OA (1) | OA10189A (de) |
| PL (1) | PL175156B1 (de) |
| PT (1) | PT696194E (de) |
| RO (1) | RO117760B1 (de) |
| RU (1) | RU2132683C1 (de) |
| SG (1) | SG43951A1 (de) |
| SK (1) | SK283353B6 (de) |
| WO (1) | WO1994025023A1 (de) |
| ZA (1) | ZA942805B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
| US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
| US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| WO1995006636A1 (en) * | 1993-08-31 | 1995-03-09 | Pfizer Inc. | 5-arylindole derivatives |
| GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| ATE224388T1 (de) * | 1994-10-12 | 2002-10-15 | Pfizer Res & Dev | Indolderivate zur behandlung von migräne |
| GB9424471D0 (en) * | 1994-12-03 | 1995-01-18 | Pfizer Ltd | Treatment of emesis |
| GB9510223D0 (en) * | 1995-05-20 | 1995-07-19 | Pfizer Ltd | Therapeutic agent |
| US5945118A (en) * | 1995-09-29 | 1999-08-31 | Pfizer Inc | Indole derivative for the treatment of migraine |
| US5773015A (en) * | 1996-11-27 | 1998-06-30 | Elizabeth Arden Co., Division Of Conopco, Inc. | Method for controlling skin oils and grease |
| GB9706089D0 (en) * | 1997-03-24 | 1997-05-14 | Scherer Ltd R P | Pharmaceutical composition |
| US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
| ES2199086B1 (es) * | 2002-07-31 | 2005-06-01 | Cepa Schwarz Pharma Sl | Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas. |
| WO2021155467A1 (en) * | 2020-02-04 | 2021-08-12 | Mindset Pharma Inc. | 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of cns disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0179053B1 (ko) * | 1990-10-15 | 1999-03-20 | 알렌 제이.스피겔 | 인돌 유도체 |
| GB9102579D0 (en) * | 1991-01-24 | 1991-03-27 | Glaxo Group Ltd | Compositions |
| GB9103770D0 (en) * | 1991-02-22 | 1991-04-10 | Glaxo Group Ltd | Chemical compounds |
-
1994
- 1994-04-07 AP APAP/P/1994/000633A patent/AP486A/en active
- 1994-04-21 IL IL10937694A patent/IL109376A/xx not_active IP Right Cessation
- 1994-04-22 ZA ZA942805A patent/ZA942805B/xx unknown
- 1994-04-25 CO CO94016790A patent/CO4230093A1/es unknown
- 1994-04-26 DE DE69431201T patent/DE69431201T2/de not_active Expired - Fee Related
- 1994-04-26 DK DK94912048T patent/DK0696194T3/da active
- 1994-04-26 NZ NZ263614A patent/NZ263614A/en unknown
- 1994-04-26 AT AT94912048T patent/ATE222492T1/de not_active IP Right Cessation
- 1994-04-26 PL PL94311266A patent/PL175156B1/pl unknown
- 1994-04-26 ES ES94912048T patent/ES2180573T3/es not_active Expired - Lifetime
- 1994-04-26 SK SK1332-95A patent/SK283353B6/sk unknown
- 1994-04-26 CN CN94191935A patent/CN1121689A/zh active Pending
- 1994-04-26 CZ CZ19952802A patent/CZ290416B6/cs not_active IP Right Cessation
- 1994-04-26 JP JP6524076A patent/JP2922307B2/ja not_active Expired - Fee Related
- 1994-04-26 AU AU64360/94A patent/AU689469B2/en not_active Ceased
- 1994-04-26 KR KR1019950704678A patent/KR960701636A/ko not_active Application Discontinuation
- 1994-04-26 CA CA002161533A patent/CA2161533C/en not_active Expired - Fee Related
- 1994-04-26 HU HU9503089A patent/HU222488B1/hu not_active IP Right Cessation
- 1994-04-26 WO PCT/IB1994/000079 patent/WO1994025023A1/en active IP Right Grant
- 1994-04-26 RO RO95-01860A patent/RO117760B1/ro unknown
- 1994-04-26 CN CNA021506892A patent/CN1515252A/zh active Pending
- 1994-04-26 SG SG1996006766A patent/SG43951A1/en unknown
- 1994-04-26 EP EP94912048A patent/EP0696194B1/de not_active Expired - Lifetime
- 1994-04-26 BR BR9406435A patent/BR9406435A/pt not_active Application Discontinuation
- 1994-04-26 CN CNA011046600A patent/CN1509713A/zh active Pending
- 1994-04-26 RU RU95120093/14A patent/RU2132683C1/ru not_active IP Right Cessation
- 1994-04-26 PT PT94912048T patent/PT696194E/pt unknown
- 1994-04-27 MX MX9403088A patent/MX9403088A/es unknown
-
1995
- 1995-10-25 BG BG100093A patent/BG61898B1/bg unknown
- 1995-10-26 NO NO954287A patent/NO308236B1/no not_active IP Right Cessation
- 1995-10-27 OA OA60728A patent/OA10189A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69431880D1 (de) | Verwendung von (2-imidazolin-2-yl-amino) quinoxalinderivaten | |
| ATE170746T1 (de) | Verwendung von tetrahydrocarbazolderivaten als 5ht1-rezeptor-agonisten | |
| DE69431201D1 (de) | Verwendung von indolderivaten als 5ht1-agonisten | |
| ATE135733T1 (de) | Quasi-azeotrope mischungen zur verwendung als kältemittel | |
| DE69627179D1 (de) | Substituierte 2-anilino-pyrimidines verwendbar als protein kinase inhibitoren | |
| DE69220382D1 (de) | Verwendung von Peptidderivaten | |
| DE69801878D1 (de) | Verwendung von Oxamatderivaten als Depigmentierungsmittel | |
| DE59409777D1 (de) | Verwendung von Acrylamidpolymeren als Faltenverhinderungsmittel | |
| DE59608154D1 (de) | Verwendung von polyasparaginsäureamiden als lederhilfsmittel | |
| BR9006950A (pt) | Compostos heterociclicos | |
| DE69617995D1 (de) | Indolalkylderivate von benzodioxanmenthylamin als 5-ht1a rezeptor liganden | |
| DE69628195D1 (de) | Verwendung von xyloglucanendotransglycosylase | |
| DE69632936D1 (de) | Verwendung von Pyrrolverbindungen als Antifouling-Wirkstoff | |
| DE59001751D1 (de) | Verwendung von di-styryl-phenyl-triglykolether als kristallisationsinhibitor. | |
| FI955164A0 (fi) | Heterosykliset johdannaiset | |
| DE69531048D1 (de) | Verwendung von steroidsulphatase-hemmern | |
| DE69827393D1 (de) | Kosmetische verwendung von bis-resorcinol-triazinderivaten | |
| DE59508900D1 (de) | Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide | |
| DE68910676D1 (de) | Verwendung von Creosot als antispastischer Wirkstoff. | |
| DE59813467D1 (de) | Verwendung von aerogelen als adsorptionsmittel | |
| DE69024524D1 (de) | Substituierte Tetrahydroindanderivate und ihre Verwendung als Zwischenprodukte | |
| DE3881270D1 (de) | Verwendung von pyrrolidon-derivaten als antiamnetikum. | |
| DE69320653D1 (de) | Tetrahydrocarbazolderivate als 5-ht1-ähnliche agonisten | |
| DE59405917D1 (de) | Epoxy-derivate von polyacrylamiden | |
| DE59401861D1 (de) | Verwendung von ferrocen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |